
The first new drug developed in over a decade for children with attention deficit hyperactivity disorder (ADHD) has been approved by the U.S. Food and Drug Administration. Qelbree, also known as viloxazine, comes in a capsule that is taken daily, and is not a stimulant. This makes it harder to abuse than older ADHD drugs,… read on > read on >